122 related articles for article (PubMed ID: 3370740)
1. Cytotoxicity of ketoconazole in malignant cell lines.
Rochlitz CF; Damon LE; Russi MB; Geddes A; Cadman EC
Cancer Chemother Pharmacol; 1988; 21(4):319-22. PubMed ID: 3370740
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells.
Eichenberger T; Trachtenberg J; Chronis P; Keating A
Clin Invest Med; 1989 Dec; 12(6):363-6. PubMed ID: 2612088
[TBL] [Abstract][Full Text] [Related]
3. The effects of ketoconazole on the human fibrosarcoma cell line HT-1080.
Shaughnessey EA; Walker MJ; Das Gupta TK
Anticancer Res; 1994; 14(2A):513-6. PubMed ID: 8017855
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
Chlebowski RT; Dietrich M; Akman S; Block JB
Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3.
Dixon SC; Zalles A; Giordano C; Lush RM; Venzon D; Reed E; Figg WD
Cancer Lett; 1997 Feb; 113(1-2):111-6. PubMed ID: 9065809
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole: a possible direct cytotoxic effect on prostate carcinoma cells.
Eichenberger T; Trachtenberg J; Toor P; Keating A
J Urol; 1989 Jan; 141(1):190-1. PubMed ID: 2908948
[TBL] [Abstract][Full Text] [Related]
7. In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).
Schroyens WA; Dodion PF; Sanders C; Loos M; Dethier NE; Delforge AR; Stryckmans PA; Kenis Y
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1135-9. PubMed ID: 3653209
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole.
Braunschweiger PG; Kumar N; Constantinidis I; Wehrle JP; Glickson JD; Johnson CS; Furmanski P
Cancer Res; 1990 Aug; 50(15):4709-17. PubMed ID: 2369744
[TBL] [Abstract][Full Text] [Related]
9. The use of 5-fluorocytosine and ketoconazole in the culture of the erythrocytic stages of Plasmodium falciparum and some tumor cell lines.
Roth EF; McKitrick JC; Herz F
Experientia; 1989 May; 45(5):478-80. PubMed ID: 2656288
[TBL] [Abstract][Full Text] [Related]
10. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines.
Blagosklonny MV; Dixon SC; Figg WD
J Urol; 2000 Mar; 163(3):1022-6. PubMed ID: 10688042
[TBL] [Abstract][Full Text] [Related]
12. In vitro screening of crude extracts and pure metabolites obtained from marine invertebrates for the treatment of breast cancer.
Stingl J; Andersen RJ; Emerman JT
Cancer Chemother Pharmacol; 1992; 30(5):401-6. PubMed ID: 1505079
[TBL] [Abstract][Full Text] [Related]
13. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
Damon LE; Christensen S; Rochlitz C; Cadman EC
Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
[TBL] [Abstract][Full Text] [Related]
14. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
Wang YJ; Jeng JH; Chen RJ; Tseng H; Chen LC; Liang YC; Lin CH; Chen CH; Chu JS; Ho WL; Ho YS
Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and murine pharmacokinetics of parenteral acronycine.
Dorr RT; Liddil JD; Von Hoff DD; Soble M; Osborne CK
Cancer Res; 1989 Jan; 49(2):340-4. PubMed ID: 2910453
[TBL] [Abstract][Full Text] [Related]
16. The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.
Tzanakakis GN; Krambovitis E; Tsatsakis AM; Vezeridis MP
Int J Gastrointest Cancer; 2002; 32(1):23-30. PubMed ID: 12630766
[TBL] [Abstract][Full Text] [Related]
17. Ethacrynic acid: a novel radiation enhancer in human carcinoma cells.
Khil MS; Kim SH; Pinto JT; Kim JH
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):375-80. PubMed ID: 8567338
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines.
Kapadia GJ; Rao GS; Ramachandran C; Iida A; Suzuki N; Tokuda H
J Complement Integr Med; 2013 Jun; 10():. PubMed ID: 23828331
[TBL] [Abstract][Full Text] [Related]
19. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
20. Growth modulation effects of synthetic steroids on rat prostatic adenocarcinoma and human breast adenocarcinoma cells in vitro.
Mickey DD; Foulkes K; Carvalho L; Kendle K; Petrow V
Anticancer Drug Des; 1990 May; 5(2):221-35. PubMed ID: 2357267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
